| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000017417 |
| Receipt No. | R000020199 |
| Official scientific title of the study | Clinical significance of urine-DPP-4 activity in patients with type2 diabetes. |
| Date of disclosure of the study information | 2015/05/04 |
| Last modified on | 2017/05/08 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Clinical significance of urine-DPP-4 activity in patients with type2 diabetes. | |
| Title of the study (Brief title) | Clinical significance of urine-DPP-4 activity in patients with type2 diabetes. | |
| Region |
|
|
| Condition | ||
| Condition | type2 diabetes mellitus | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the clinical significance and to explore the possibility of urine-DPP-4 activity as a clinical biomarker for glucose homeostasis in healthy volunteer and patients with type2 diabetes. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Serum-DPP-4 activity , urine-DPP-4 activity and metabolic marker ( body weight, plasma
levels of glucose, insulin, lipids ) of healthy volunteer and type2 diabetes patients. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 60 type 2 diabetes patients and 20 healthy volunteer | |||
| Key exclusion criteria | 1.subjects who have severe renal dysfunction
2. subjects who have severe liver dysfunction 3. subjects who have insulin administration. 4. subjects who have malignant tumor. 5. expected, pregnant or lactating woman. 6. subjects to be inappropriate as an object of this examination by other reasons. And, medical staff and students. |
|||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroaki Masuzaki,MD,phD |
| Organization | Faculty of Medicine, University of the Ryukyus |
| Division name | Second Department of Internal Medicine |
| Address | 207 Uehara, Nishihara, Okinawa |
| TEL | 098-895-1146 |
| ikyoku@ryudai2nai.com | |
| Public contact | |
| Name of contact person | Rei Ueda, MD |
| Organization | Faculty of Medicine, University of the Ryukyus |
| Division name | Second Department of Internal Medicine |
| Address | 207 Uehara, Nishihara, Okinawa |
| TEL | 098-895-1146 |
| Homepage URL | |
| ikyoku@ryudai2nai.com | |
| Sponsor | |
| Institute | Second Department of Internal Medicine,Second Department of Internal Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Second Department of Internal Medicine,Second Department of Internal Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 琉球大学医学部附属病院第2内科(沖縄県)
宜野湾海邦病院(沖縄県) 沖縄赤十字病院(沖縄県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | To clarify the clinical significance and to explore the possibility of urine-DPP-4 activity as a clinical biomarker for glucose homeostasis in healthy volunteer and patients with type2 diabetes. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020199 |